Oxygenta Pharmaceutical share news, announcements and annual reports
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹47.86.
30 Oct: open ₹47.01, high ₹48.21, low ₹46.89
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹175 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,027
Oxygenta Pharmaceutical share news and announcements
489 announcements, routine notices left out, newest first. Page 5 of 10.
Jan 2023
Nov 2022
26 Nov · Related Party Transactions Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2022
3 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Oct 2022
10 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
Aug 2022
8 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results
Jul 2022
11 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
28 Jun · Announcement under Regulation 30 (LODR)-Change of Company Name
6 Jun · Sub: Related Party Transactions Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2022.
May 2022
16 May · Board meeting
Meeting on 20 May 2022: audited results
Apr 2022
30 Apr · Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015.
27 Apr · Related Party Transactions Revised Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2021.
18 Apr · Revised Disclosure On Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2021
18 Apr · Revised Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2021
16 Apr · Compliance Certificate For The Period Ended 31-03-2022
11 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2022
11 Feb · Announcement under Regulation 30 (LODR)-Change of Company Name
8 Feb · Board meeting
Meeting on 14 Feb 2022: quarterly results
Jan 2022
21 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....4 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 04 Jan · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/524636 ....
Dec 2021
7 Dec · Request For Re-Classification Of Promoter Group To Public Group
6 Dec · Board meeting
Meeting on 6 Dec 2021: annual general meeting
Nov 2021
8 Nov · Board meeting
Meeting on 15 Nov 2021: quarterly results
Oct 2021
8 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....4 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0